Across TCGA pan-cancer cohorts, FLNB RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated FLNB data layer compared with 7 for mutation status and 6 for mass-spec protein.
The strongest signal is observed in mesothelioma (MESO), where higher FLNB RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FLNB expression acts as an unfavorable survival marker, although some lineages such as KIRC and BRCA show a favorable association.
MESO, KIRC, and BRCA are the cancer types where FLNB RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.